MedTrace Logo

Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)

NCT01822119 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2017-02-06

Study results available
· View outcomes & findings →

Summary

The rationale behind this clinical performance investigation is to collect data regarding the usability of the Baha Attract System in patients with hearing impairment that are candidates for Baha surgery:

* To describe the expected hearing performance with the Baha Attract in comparison to unaided hearing thresholds or a pre-test situation using a sound processor together with a softband
* Which sound processor to select, i.e. BP100 vs BP110
* Improve the fitting process for the sound processor
* Selection of sound processor magnet at time of fitting and over time

Conditions

Interventions

DEVICE

Baha Attract System

Sponsors & Collaborators

  • Cochlear Bone Anchored Solutions

    lead INDUSTRY

Principal Investigators

  • Robert Cowan, A/Professor · The HEARing CRC & HearWorks, University of Melbourne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Australia
  • Chile
  • Hong Kong
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01822119 on ClinicalTrials.gov